Ultragenyx Pharmaceutical | RARE - Stock



Ultragenyx Pharmaceutical reported $46.5M in Stock for its fiscal quarter ending in June of 2025.


Stock Change Date
Acadia Pharmaceuticals USD 26.12M 3.18M Jun/2025
Agios Pharmaceuticals USD 30.85M 1.24M Jun/2025
Alnylam Pharmaceuticals USD 71.69M 6.11M Jun/2025
BioMarin Pharmaceutical USD 1.34B 65.32M Jun/2025
Insmed USD 107.6M 6.89M Jun/2025
Ionis Pharmaceuticals USD 8.48M 3.02M Jun/2025
Kyowa Hakko Kirin JPY 73.16B 116M Mar/2025
MacroGenics USD 9.28M 9.28M Jun/2025
Moderna USD 240M 112M Jun/2025
Neurocrine Biosciences USD 56.9M 2.2M Jun/2025
PTC Therapeutics USD 34.06M 12.39M Jun/2025
Regeneron Pharmaceuticals USD 3.21B 760.7M Jun/2025
Sarepta Therapeutics USD 994.04M 52.6M Jun/2025
Ultragenyx Pharmaceutical USD 46.5M 467K Jun/2025
Vertex Pharmaceuticals USD 1.5B 139.6M Jun/2025